In contrast, tirzepatide shows promising cardiovascular potential, but these effects are still under ongoing clinical research
What sets it apart from Ipamorelin: Sermorelin was FDA-approved under the brand name Geref first as a diagnostic agent in 1990, then for GH deficiency in children in 1997 (Federal Register, PubMed)
According to FDA prescribing information, constipation occurs in 16-24% of Wegovy patients and 5-17% of Ozempic patients (dose-dependent), while diarrhea occurs in 11-30% of patients across products and doses
Same dose, different volumes
Beyond these general guidelines, ideal candidates for GLP-1 therapy at Vital Health Medical Care include individuals who have struggled to achieve meaningful weight loss through diet and exercise alone, those with a personal or family history of metabolic conditions such as diabetes or cardiovascular disease, women navigating post-pregnancy weight challenges, and patients who have previously lost weight through other means but have experienced significant regain
GLP-1 medications can be helpful for many patients, but they are not the right long-term answer for everyone